Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic (Q37376094)
Jump to navigation
Jump to search
scientific article published on 22 May 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic |
scientific article published on 22 May 2016 |
Statements
1 reference
Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic (English)
1 reference
David A Tuveson
1 reference
Robert H Mach
1 reference
Kerri A Ohman
1 reference
Yassar M Hashim
1 reference
Suwanna Vangveravong
1 reference
Timothy M Nywening
1 reference
Darren R Cullinan
1 reference
S Peter Goedegebuure
1 reference
Jingxia Liu
1 reference
Brian A Van Tine
1 reference
David G DeNardo
1 reference
Dirk Spitzer
1 reference
William G Hawkins
1 reference
1 reference
1 reference
Identifiers
1 reference